Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bird Flu
New bird flu study findings have been reported by scientists at Shiga University
August 13th, 2008
According to recent research published in the journal Immunology, "We investigated whether a vaccine derived from an apathogenic reassortant type A H5N1 influenza strain could induce immune responses in vivo that mediated protection from highly pathogenic avian influenza virus infection in mice. After two subcutaneous immunizations with formalin-inactivated H5N1 whole virus particles (whole particle vaccine), significant killing specific for cells presenting a nucleoprotein peptide from the vaccine strain of the virus was observed." "Similar vaccination with viruses treated with ether and formalin, which are commonly used for humans as ether-split vaccines,...
Source: Vaccine Weekly (2008-08-13)
|
